NCT01669382View on ClinicalTrials.gov

Angio-Seal® vs. Exo-Seal® for Closure of Arterial Puncture Sites

PHASE3CompletedINTERVENTIONAL
Enrollment

304

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Acute Coronary SyndromesStable Angina Pectoris
Interventions
DEVICE

percutaneous coronary intervention

after the intervention patients are randomized to either Angio Seal or Exo Seal

Trial Locations (3)

35392

Universitätsklinikum Gießen, Klinik für Kardiologie, Giessen

91054

Universitätsklinikum Erlangen; Medizinische Klinik 2, Erlangen

96450

Klinikum Coburg, Coburg

All Listed Sponsors
lead

University Hospital Erlangen

OTHER

NCT01669382 - Angio-Seal® vs. Exo-Seal® for Closure of Arterial Puncture Sites | Biotech Hunter | Biotech Hunter